CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Treatment outcome in patients with triple negative early stage breast cancers compared with other molecular subtypes
Ja Young Kim, Sei-Kyung Chang, Heily Park, Bo-Mi Lee, Hyun Soo Shin
Radiation Oncology Journal. 2012;30(3):124-131.   Published online 2012 September 30    DOI: https://doi.org/10.3857/roj.2012.30.3.124

Excel Download

Treatment outcome in patients with triple negative early stage breast cancers compared with other molecular subtypes
Radiation Oncology Journal. 2012;30(3):124   Crossref logo
Link1 Link2 Link3

Genomic and transcriptomic landscape of triple-negative breast cancers: subtypes and treatment strategies
The Breast. 2019;44:S27   Crossref logo
Link1 Link2

Cisplatin–gemcitabine therapy in metastatic breast cancer: Improved outcome in triple negative breast cancer patients compared to non-triple negative patients
The Breast. 2010;19(3):246-248   Crossref logo
Link1 Link2

Early Stage Triple Negative and HER2 Overexpression Breast Cancers Have Similar Survivals in Chinese Patients
The Breast Journal. 2012;18(3):286-288   Crossref logo
Link1 Link2

Outcome After Breast Conservation Treatment with Radiation for Women with Triple-Negative Early-Stage Invasive Breast Carcinoma
Clinical Breast Cancer. 2009;9(2):96-100   Crossref logo
Link1 Link2

Elevated preoperative serum levels of collagen I carboxyterminal telopeptide predict better outcome in early-stage luminal-B-like (HER2-negative) and triple-negative subtypes of breast cancer
Tumor Biology. 2019;41(5):101042831984708   Crossref logo
Link1 Link2 Link3

Expression of HIF-1α and Markers of Angiogenesis Are Not Significantly Different in Triple Negative Breast Cancer Compared to Other Breast Cancer Molecular Subtypes: Implications for Future Therapy
PLOS ONE. 2015;10(6):e0129356   Crossref logo
Link1

Changing frameworks in treatment sequencing of triple-negative and HER2-positive, early-stage breast cancers
The Lancet Oncology. 2019;20(7):e390-e396   Crossref logo
Link1 Link2

A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer
Breast Cancer Research. 2010;12(5):   Crossref logo
Link1 Link2 Link3

Early Triple Negative Breast Cancer: Conventional Treatment and Emerging Therapeutic Landscapes
Cancers. 2020;12(4):819   Crossref logo
Link1

This metadata service is kindly provided by CrossRef from May 29, 2014. Radiat Oncol J has participated in CrossRef Text and Data Mining service since October 29, 2014.